Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial-Reference-Cited by-同舟云学术

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

Published:2008-07 Issue:9632 Volume:372 Page:31-39
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kakkar Ajay K,Brenner Benjamin,Dahl Ola E,Eriksson Bengt I,Mouret Patrick,Muntz Jim,Soglian Andrea G,Pap Ákos F,Misselwitz Frank,Haas Sylvia

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial;Kakkar;Lancet,1975

2. Prevention of venous thrombosis and pulmonary embolism;NIH consensus statement,1986

3. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Geerts;Chest,2004

4. Prophylaxis of venous thromboembolism. A national clinical guideline,2002

Cited by 919 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of commonly used thromboprophylaxis agents following hip and knee arthroplasty;The Bone & Joint Journal;2024-09-01

2. Antithrombotic prophylaxis following total knee arthroplasty: a level I Bayesian network meta-analysis;European Journal of Orthopaedic Surgery & Traumatology;2024-08-10

3. Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis;Seminars in Thrombosis and Hemostasis;2024-07-01

4. A systematic review and meta-analysis of the morbidity of efficacy endpoints and bleeding events in elderly and young patients treated with the same dose rivaroxaban;Annals of Hematology;2024-05-07

5. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?;The Pharmacogenomics Journal;2024-03-05